Clinical Trial Update: CA-125 in Screening Patients at High Risk for Ovarian Cancer

View source ↗

Summary

Clinical trial evaluating CA-125 screening for women at high risk of ovarian cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Ovarian Cancer | Status: WITHDRAWN